Insufficient scRNA-seq data for expression of GDPD2 at single-cell level.
Insufficient scRNA-seq data for expression of GDPD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 84% | 451.90 | 2209 / 2642 | 98% | 20.87 | 693 / 705 |
intestine | 38% | 474.71 | 366 / 966 | 64% | 2.74 | 337 / 527 |
spleen | 100% | 10057.69 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.17 | 1 / 1 |
bladder | 24% | 47.95 | 5 / 21 | 59% | 8.04 | 298 / 504 |
skin | 71% | 1423.29 | 1281 / 1809 | 10% | 0.30 | 49 / 472 |
stomach | 20% | 34.01 | 71 / 359 | 60% | 2.59 | 172 / 286 |
ovary | 1% | 0.65 | 1 / 180 | 66% | 4.91 | 282 / 430 |
pancreas | 0% | 0 | 0 / 328 | 62% | 2.72 | 110 / 178 |
esophagus | 2% | 3.71 | 29 / 1445 | 53% | 3.99 | 97 / 183 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.18 | 16 / 45 |
kidney | 19% | 62.42 | 17 / 89 | 13% | 0.36 | 114 / 901 |
uterus | 0% | 0 | 0 / 170 | 31% | 2.16 | 140 / 459 |
lung | 0% | 0 | 0 / 578 | 26% | 1.85 | 304 / 1155 |
breast | 0% | 2.23 | 1 / 459 | 15% | 1.27 | 165 / 1118 |
eye | 0% | 0 | 0 / 0 | 5% | 0.27 | 4 / 80 |
adrenal gland | 0% | 0 | 0 / 258 | 4% | 0.09 | 10 / 230 |
blood vessel | 1% | 2.53 | 17 / 1335 | 0% | 0 | 0 / 0 |
adipose | 1% | 5.70 | 12 / 1204 | 0% | 0 | 0 / 0 |
prostate | 0% | 0.57 | 1 / 245 | 0% | 0.00 | 2 / 502 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0007015 | Biological process | actin filament organization |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005884 | Cellular component | actin filament |
GO_0008889 | Molecular function | glycerophosphodiester phosphodiesterase activity |
GO_0047394 | Molecular function | glycerophosphoinositol inositolphosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GDPD2 |
Protein name | Glycerophosphoinositol inositolphosphodiesterase GDPD2 (EC 3.1.4.43) (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor) |
Synonyms | UNQ1935/PRO4418 OBDPF GDE3 |
Description | FUNCTION: Has glycerophosphoinositol inositolphosphodiesterase activity and specifically hydrolyzes glycerophosphoinositol, with no activity for other substrates such as glycerophosphoinositol 4-phosphate, glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. Accelerates the program of osteoblast differentiation and growth. May play a role in remodeling of the actin cytoskeleton (By similarity). . |
Accessions | ENST00000453994.6 [Q9HCC8-3] ENST00000374382.4 [Q9HCC8-1] Q9HCC8 ENST00000536730.5 [Q9HCC8-2] ENST00000538649.5 [Q9HCC8-2] |